Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01720446

Public ClinicalTrials.gov record NCT01720446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term, Randomised, Double-blind, Placebo-controlled, Multinational, Multi-centre Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (SUSTAIN™ 6 - Long-term Outcomes)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of the trial is to evaluate cardiovascular and other long-term outcomes with semaglutide in subjects with type 2 diabetes. The trial is event-driven, i.e. the maximum trial duration (up to max. 148 weeks) will depend on the accrual of major adverse cardiovascular events (MACE) in this trial and the remaining research programme. The incidence of MACE will be monitored throughout the trial which will be terminated according to plan when pre-specified stopping criteria are met.

Study identification

NCT ID
NCT01720446
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
3,297 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2013
Primary completion
Mar 14, 2016
Completion
Mar 14, 2016
Last update posted
Jun 26, 2019

2013 – 2016

United States locations

U.S. sites
97
U.S. states
31
U.S. cities
87
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35205-4731
Novo Nordisk Investigational Site Birmingham Alabama 35216
Novo Nordisk Investigational Site Chandler Arizona 85224
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Greenbrae California 94904
Novo Nordisk Investigational Site Lancaster California 93534
Novo Nordisk Investigational Site Los Angeles California 90017-4006
Novo Nordisk Investigational Site Mission Hills California 91345
Novo Nordisk Investigational Site Monterey California 93940
Novo Nordisk Investigational Site Northridge California 91325
Novo Nordisk Investigational Site San Diego California 92108
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Ventura California 93003
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Crystal River Florida 34429
Novo Nordisk Investigational Site DeLand Florida 32724
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Melbourne Florida 32901
Novo Nordisk Investigational Site Melbourne Florida 32934
Novo Nordisk Investigational Site Ocala Florida 34470
Novo Nordisk Investigational Site Ponte Vedra Florida 32081
Novo Nordisk Investigational Site Spring Hill Florida 34609
Novo Nordisk Investigational Site St. Petersburg Florida 33707
Novo Nordisk Investigational Site Dunwoody Georgia 30338
Novo Nordisk Investigational Site Lawrenceville Georgia 30046
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Crystal Lake Illinois 60012
Novo Nordisk Investigational Site Gurnee Illinois 60031
Novo Nordisk Investigational Site Michigan City Indiana 46360
Novo Nordisk Investigational Site Mishawaka Indiana 46544
Novo Nordisk Investigational Site Wichita Kansas 67205
Novo Nordisk Investigational Site Louisville Kentucky 40206
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Monroe Louisiana 71203
Novo Nordisk Investigational Site New Orleans Louisiana 70112
Novo Nordisk Investigational Site Methuen Massachusetts 01844
Novo Nordisk Investigational Site North Dartmouth Massachusetts 02747
Novo Nordisk Investigational Site Kalamazoo Michigan 49048
Novo Nordisk Investigational Site Chesterfield Missouri 63017
Novo Nordisk Investigational Site Kansas City Missouri 64111
Novo Nordisk Investigational Site St Louis Missouri 63128
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Omaha Nebraska 68198-3020
Novo Nordisk Investigational Site Lebanon New Hampshire 03756
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Mine Hill New Jersey 07803
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site New York New York 10001
Novo Nordisk Investigational Site Rochester New York 14609
Novo Nordisk Investigational Site Staten Island New York 10301
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Asheboro North Carolina 27203
Novo Nordisk Investigational Site Asheville North Carolina 28801
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Raleigh North Carolina 27612
Novo Nordisk Investigational Site Whiteville North Carolina 28472
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Cincinnati Ohio 45219
Novo Nordisk Investigational Site Cleveland Ohio 44106
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Mason Ohio 45040-6815
Novo Nordisk Investigational Site Maumee Ohio 43537
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104
Novo Nordisk Investigational Site Beaver Pennsylvania 15009-1957
Novo Nordisk Investigational Site McMurray Pennsylvania 15317
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572
Novo Nordisk Investigational Site Bartlett Tennessee 38133
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Memphis Tennessee 38163
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Dallas Texas 75218
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Fort Worth Texas 76132
Novo Nordisk Investigational Site Houston Texas 77074
Novo Nordisk Investigational Site Irving Texas 75061-2210
Novo Nordisk Investigational Site Longview Texas 75605
Novo Nordisk Investigational Site Odessa Texas 79761
Novo Nordisk Investigational Site Plano Texas 75075
Novo Nordisk Investigational Site San Antonio Texas 78224
Novo Nordisk Investigational Site San Antonio Texas 78228-3419
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site South Burlington Vermont 05403-7205
Novo Nordisk Investigational Site Richmond Virginia 23219
Novo Nordisk Investigational Site Winchester Virginia 22601-3834
Novo Nordisk Investigational Site Winchester Virginia 22601
Novo Nordisk Investigational Site Wenatchee Washington 98801-2028
Novo Nordisk Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 156 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01720446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01720446 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →